Medicare Enrolled
Dr. James Calmes, MD, MBA
Rheumatology · Lubbock, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Calmes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Calmes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Calmes
Dr. James Calmes is a rheumatology specialist in Lubbock, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Calmes performed 45,739 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Calmes received a total of $6,772 from 25 pharmaceutical and/or device companies across 543 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Calmes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 25% volume in TX
$6,772 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗45,739
Medicare services
Top 25% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
23,145 | $11 | $49 |
| Denosumab injection (Prolia/Xgeva) | 11,220 | $18 | $35 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
7,302 | $24 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
593 | $57 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
496 | $7 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
401 | $7 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
348 | $21 | $70 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
321 | $10 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
256 | $95 | $300 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
245 | $4 | $12 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
192 | $5 | $36 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
192 | $11 | $50 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
138 | $48 | $125 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
129 | $17 | $50 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
105 | $27 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $85 | $207 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
86 | $11 | $35 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
61 | $2 | $10 |
| Rheumatoid factor level | 56 | $5 | $20 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
45 | $8 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $107 | $318 |
| Liver function blood test panel | 38 | $7 | $25 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
36 | $21 | $50 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
34 | $5 | $15 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
33 | $13 | $40 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
30 | $36 | $200 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
26 | $25 | $62 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
20 | $6 | $20 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
17 | $4 | $15 |
| Acute hepatitis panel A blood test that screens for markers of acute viral hepatitis infection. |
13 | $47 | $140 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
13 | $5 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
67.4% high complexity
25.7% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,772
Total received (2018-2024)
Avg $967/year across 7 years
Top 41% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
543
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,016
2023
$929
2022
$636
2021
$918
2020
$687
2019
$1,207
2018
$1,379
Payments by company (2024)
Amgen Inc.
$396
ABBVIE INC.
$353
UCB, Inc.
$176
GlaxoSmithKline, LLC.
$32
ANI Pharmaceuticals, Inc.
$23
Novartis Pharmaceuticals Corporation
$20
DePuy Synthes Sales Inc.
$16
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,900
UCB, Inc.
$1,087
AbbVie Inc.
$739
ABBVIE INC.
$587
AbbVie, Inc.
$472
Novartis Pharmaceuticals Corporation
$335
Janssen Biotech, Inc.
$274
GlaxoSmithKline, LLC.
$234
PFIZER INC.
$232
Genentech USA, Inc.
$213
Radius Health, Inc.
$97
Horizon Therapeutics plc
$94
DePuy Synthes Sales Inc.
$87
AstraZeneca Pharmaceuticals LP
$83
Horizon Pharma plc
$60
Bioventus LLC
$52
Merck Sharp & Dohme Corporation
$46
Celgene Corporation
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Janssen Scientific Affairs, LLC
$27
ANI Pharmaceuticals, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$16
Flexion Therapeutics, Inc.
$15
Lilly USA, LLC
$13
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 55.0% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Durolane · EVENITY · Enbrel · HUMIRA · Humira · INFLECTRA · KRYSTEXXA · MONOVISC · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
4
County median income
$63,367
Nearest hospital to ZIP centroid (approximate)
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Calmes is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Calmes experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Calmes performed 23,145 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Calmes receive payments from pharmaceutical companies?
Yes. Dr. Calmes received a total of $6,772 from 25 companies across 543 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Calmes's costs compare to other rheumatologists in Lubbock?
Dr. Calmes's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Calmes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Lubbock
Browse rheumatologists in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology